Related references
Note: Only part of the references are listed.Human Biomarkers of Rapid Antidepressant Effects
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2013)
Toward a Systems Biology of Mood Disorder
Andrew M. McIntosh
BIOLOGICAL PSYCHIATRY (2013)
Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses
Bhavya Voleti et al.
BIOLOGICAL PSYCHIATRY (2013)
Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression
Allison C. Nugent et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study
G. I. Papakostas et al.
MOLECULAR PSYCHIATRY (2013)
2012 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2013)
Neuroimaging in Psychiatric Pharmacogenetics Research: The Promise and Pitfalls
Mary Falcone et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Potential of Pretreatment Neural Activity in the Visual Cortex During Emotional Processing to Predict Treatment Response to Scopolamine in Major Depressive Disorder
Maura L. Furey et al.
JAMA PSYCHIATRY (2013)
Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression
David A. Luckenbaugh et al.
BIPOLAR DISORDERS (2012)
Pharmacogenetically Driven Treatments for Alcoholism
Albert J. Arias et al.
CNS DRUGS (2012)
Surrogate markers of treatment outcome in major depressive disorder
George I. Papakostas
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease
Na-Young Han et al.
JOURNAL OF DIGESTIVE DISEASES (2012)
NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia
Alan Anticevic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Data sharing in neuroimaging research
Jean-Baptiste Poline et al.
FRONTIERS IN NEUROINFORMATICS (2012)
Monitoring Ketamine treatment Response in a Depressed Patient via Peripheral Mammalian target of Rapamycin Activation
Magdalena C. Denk et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Using Computational Patients to Evaluate Illness Mechanisms in Schizophrenia
Ralph E. Hoffman et al.
BIOLOGICAL PSYCHIATRY (2011)
Acute Hydrocortisone Treatment Increases Anxiety but Not Fear in Healthy Volunteers: A Fear-Potentiated Startle Study
Christian Grillon et al.
BIOLOGICAL PSYCHIATRY (2011)
The size and burden of mental disorders and other disorders of the brain in Europe 2010
H. U. Wittchen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
James D. Lewis
GASTROENTEROLOGY (2011)
Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia
William E. Klunk
NEUROBIOLOGY OF AGING (2011)
Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders
Thomas Insel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Clinical Implications of the Cytokine Hypothesis of Depression: The Association between Use of Statins and Aspirin and the Risk of Major Depression
Julie A. Pasco et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2010)
Is Pharma Running Out of Brainy Ideas?
Greg Miller
SCIENCE (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Translational Medicine and the Value of Biomarker Qualification
Federico M. Goodsaid et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Family History of Alcohol Dependence and Initial Antidepressant Response to an N-methyl-D-aspartate Antagonist
Laura E. Phelps et al.
BIOLOGICAL PSYCHIATRY (2009)
Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine
Giacomo Salvadore et al.
BIOLOGICAL PSYCHIATRY (2009)
Biochemical markers and the FDA Critical Path: How biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development
M. A. Karsdal et al.
BIOMARKERS (2009)
The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders
Rodrigo Machado-Vieira et al.
NEUROSCIENTIST (2009)
Strategic approach to fit-for-purpose biomarkers in drug development
John A. Wagner
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective
Shashi Amur et al.
BIOMARKERS IN MEDICINE (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Suicide attempts among patients starting depression treatment with medications or psychotherapy
Gregory E. Simon et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Identifying functional neuroimaging biomarkers of bipolar disorder:: Toward DSM-V
Mary L. Phillips et al.
SCHIZOPHRENIA BULLETIN (2007)
Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies
H. G. Ruhe et al.
MOLECULAR PSYCHIATRY (2007)
Antidepressant efficacy of the antimuscarinic drug scopolamine - A randomized, placebo-controlled clinical trial
Maura L. Furey et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Biomarkers of cardiovascular disease - Molecular basis and practical considerations
Ramachandran S. Vasan
CIRCULATION (2006)
Fit-for-purpose method development and validation for successful biomarker measurement
JW Lee et al.
PHARMACEUTICAL RESEARCH (2006)
Suicide risk during antidepressant treatment
GE Simon et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Defining response in migraine: Which endpoints are important?
J Edmeads
EUROPEAN NEUROLOGY (2005)
Antidepressants and the risk of suicidal behaviors
H Jick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Share Paper
